Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data

Meir Schechter; Cheli Melzer Cohen; Tamir Zelter; Ilan Yanuv; Aliza Rozenberg; Gabriel Chodick; Avraham Karasik; Ofri Mosenzon

doi:10.1111/dom.15172

Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data

Diabetes Obes Metab. 2023 Oct;25(10):3054-3058. doi: 10.1111/dom.15172. Epub 2023 Jun 29.

Authors

Meir Schechter^{1

2

3}, Cheli Melzer Cohen⁴, Tamir Zelter^{1

2}, Ilan Yanuv^{1

2}, Aliza Rozenberg^{1

2}, Gabriel Chodick^{4

5}, Avraham Karasik^{4

6}, Ofri Mosenzon^{1

2}

Affiliations

¹ Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.
² Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
³ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
⁴ Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel-Aviv, Israel.
⁵ School of Public Health Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁶ Tel Aviv University, Tel Aviv, Israel.

PMID: 37385956
DOI: 10.1111/dom.15172

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Dipeptidyl-Peptidase IV Inhibitors* / pharmacology
Dipeptidyl-Peptidase IV Inhibitors* / therapeutic use
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Glucose
Hospitalization
Humans
Hypoglycemic Agents / therapeutic use
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy
Renal Insufficiency, Chronic* / epidemiology
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Dipeptidyl-Peptidase IV Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Glucose
Sodium